2019
ACTR-68. FEASIBILITY STUDY OF THE EMULATE THERAPEUTICS™ VOYAGER SYSTEM IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM)
Barkhoudarian G, Badruddoja M, Blondin N, Chen R, Chowdhary S, Cobbs C, Dowling A, Duic P, Flores J, Fonkem E, McClay E, Nabors L, Salacz M, Vaillant B, Kesari S. ACTR-68. FEASIBILITY STUDY OF THE EMULATE THERAPEUTICS™ VOYAGER SYSTEM IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM). Neuro-Oncology 2019, 21: vi29-vi29. PMCID: PMC6847970, DOI: 10.1093/neuonc/noz175.109.Peer-Reviewed Original ResearchSerious adverse eventsAdverse eventsRecurrent glioblastomaOverall survivalOutcome measuresDevice-related serious adverse eventsMedian overall survivalProgression-free survivalSecondary outcome measuresFurther prospective studiesPrimary outcome measureLong-term treatmentMulti-center studyAnti-cancer therapyProspective studyTreatment groupsFeasible treatmentPatientsBrain cancerInvestigator's choiceInvestigational deviceChemotherapyGlioblastomaMonthsTreatment
2014
Primary CNS Lymphoma
Blondin N, Baehring J, Hochberg F. Primary CNS Lymphoma. 2014, 308-315. DOI: 10.1002/9781118589199.ch48.Peer-Reviewed Original ResearchPrimary CNS lymphomaCNS lymphomaPrimary central nervous system lymphomaCentral nervous system lymphomaNervous system lymphomaCerebral biopsyIntrathecal chemotherapySystem lymphomaInitial treatmentOcular lymphomaDifferential diagnosisRadiation therapyBrain tumorsLymphomaPatientsCurrent standardCorticosteroidsChemotherapyBiopsyPrognosisTherapyTumorsMultiple-choice questionsDiagnosisCare
2012
Anaplastic Gliomas Radiation, Chemotherapy, or Both?
Blondin NA, Becker KP. Anaplastic Gliomas Radiation, Chemotherapy, or Both? Hematology/Oncology Clinics Of North America 2012, 26: 811-823. PMID: 22794285, DOI: 10.1016/j.hoc.2012.04.003.Peer-Reviewed Original Research